Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz
|Bid||45.85 x 500|
|Ask||456.00 x 2000|
|Day's Range||48.60 - 49.95|
|52 Week Range||20.19 - 51.49|
|PE Ratio (TTM)||-62.77|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||41.50|
Mazor Robotics Ltd. , a pioneer and a leader in the field of surgical robotic systems, announced today CE Mark approval for its Mazor X Surgical Assurance Platform.
Illumina, Mazor Robotics, and Novocure are on the cutting edge of healthcare innovation. That could make them perfect stocks to own in growth portfolios.
These three promising companies offer market-beating returns for years to come.